Wed.Sep 21, 2022

article thumbnail

Citation Laureates 2022: Nobel class researchers who are changing the world

Clarivate

Clarivate draws on Web of Science publication and citation data to produce an annual list of Citation Laureates – researchers of Nobel class whose high-impact contributions have transformed their fields and changed our world for the better. Every October, the world watches as the Nobel Assembly votes to confer their prestigious prizes. While people around the globe can’t help but speculate about who will be chosen, Clarivate is the only organization to use quantitative data in addition to qualit

article thumbnail

AstraZeneca’s Tezspire for severe asthma gets green light in EU

pharmaphorum

The European Commission has followed the lead of the US FDA and approved AstraZeneca’s Tezspire as an add-on maintenance therapy for patients with severe asthma, becoming the first and only biologic that can be used in all patients, and not restricted to those with specific forms of the disease. Tezspire (tezepelumab) has been cleared for use in patients 12 years and older with severe asthma who are inadequately controlled with high dose inhaled corticosteroids plus another medicinal produ

Sales 109
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

FDA finally signs off on Fennec Pharma drug for chemo-caused hearing loss in kids

MedCity News

A Fennec Pharmaceuticals drug that prevents hearing loss in children receiving cancer treatment is now approved. The regulatory decision comes more than two years later than expected, but the company now claims its drug, Pedmark, is the first and only FDA-approved therapy for reducing the risk of chemotherapy-induced hearing loss in pediatric cancer patients.

FDA 98
article thumbnail

EMA human medicines committee (CHMP) highlights, September 2022

European Pharmaceutical Review

In its first meeting since July, the European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) recommended these 12 medicines for approval: Beyfortus (nirsevimab) for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in newborns and infants during their first RSV season (when there is a risk of RSV infection in the community).

article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

article thumbnail

Is Your Demand Side Platform (DSP) Ready for the Cookieless Future?

PharmExec

A cookieless future is on the horizon, so marketers across all industries are being forced to rethink their strategies and plan for the future. What does that entail?

article thumbnail

Patient centricity is becoming business critical for pharma

pharmaphorum

New book sets the pharmaceutical industry on a course for bridging the patient centricity optimism gap. Bridging the gulf between patient centricity ambition and reality has never been more important for pharma – luckily, this seemingly insurmountable goal isn’t as far out of reach as many envision. That’s according to Sharon Suchotliff, patient centricity lead at consultancy firm ZS Associates, which has just published a book on the art of patient involvement.

Pharma 97

More Trending

article thumbnail

Understanding the Role of Preprints & Postprints & The Version of Record

Copyright Clearance Center

The post Understanding the Role of Preprints & Postprints & The Version of Record appeared first on Copyright Clearance Center.

98
article thumbnail

Digital bloomers, hivemind investors, metaverse citizens and TikTokers: How the future of innovation is being shaped today

MedCity News

New consumer and employee personas have emerged during the pandemic and healthcare organizations must pay attention to these new pivotal groups — such as young workers who only know work-from-home and people who make investment decisions based on social media — in order to stay relevant in a post-pandemic world.

Media 97
article thumbnail

Hetero Labs Limited-Walk-In Interviews for EHS- Process Safety Management/ Process Safety Lab On 24th Sept’ 2022

Pharma Pathway

Hetero Labs Limited-Walk-In Interviews for EHS- Process Safety Management/ Process Safety Lab On 24th Sept’ 2022. Job Description. Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”. Hetero’s business includes APIs, generic, biosimilars, custom pharmaceutical services, and branded generics.

Safety 83
article thumbnail

6 Strategies Every Door to Door Sales Rep Should Use

Map My Customers

Even in 2022, there are plenty of solid reasons for salespeople to knock doors: there’s a low overhead cost, you avoid spam filters, there’s less competition, and, by meeting face-to-face, you increase brand recognition. But door-to-door sales is one of the most infamously challenging types of selling. It takes a lot of courage to go to a stranger’s front porch.

Sales 82
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Genetically modified herpes combats advanced cancers

PharmaTimes

A new genetically engineered virus has delivered a one-two punch in initial phase 1 trial

article thumbnail

HLTH executive offers sneak preview of fifth annual conference [Sponsored]

MedCity News

In an interview, HLTH’s Head of Content Jody Tropeano shares how the annual conference has adopted a festival-like vibe with an innovative layout to maximize interaction, with content highlighting topics such as women’s health, wellness, and employer health.

88
article thumbnail

AstraZeneca’s Tezspire approved in the EU for patients with severe asthma

PharmaTimes

Tezspire is a maintenance therapy for patients with no phenotype or biomarker limitations

article thumbnail

Rocket agrees to acquire biotech firm Renovacor

Pharmaceutical Technology

Rocket Pharmaceuticals has entered a definitive agreement for the acquisition of biotechnology firm Renovacor in an all-stock equity deal worth nearly $53m, or $2.60 for each share. Renovacor focuses on offering precision treatments for genetic cardiovascular and mechanistically-related ailments. The most advanced programme of the company is adeno-associated virus (AAV)-based gene therapy, REN-001.

article thumbnail

Accelerating Clinical Supply Through Integrated Drug Development

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

article thumbnail

13th PM Society Digital Awards – celebrating creative innovation

pharmaphorum

Although a tone of respectful sobriety lay over the PM Society Awards this year, as the nation’s citizens came from far and wide to London to pay their final respects to Her Majesty Queen Elizabeth II, Thursday 15 th September was, nonetheless, in equal measure an evening that paid serious homage to the best and brightest in creative digital innovation and its effectiveness within the healthcare arena.

article thumbnail

Zydus Lifesciences -Walk-In Interviews for QA/ Production/ QC On 25th Sept’ 2022

Pharma Pathway

Zydus Lifesciences -Walk-In Interviews for QA/ Production/ QC On 25th Sept’ 2022. Job Description. Walk-In Interviews for QA/ Production/QC @ Zydus Lifesciences . We are recruiting for our formulation Manufacturing plant based out of Ahmedabad. Production Department: Officer to Manager: (Production): B.Pharma / M.Pharm/ B.Sc/ M.Sc with 2-16 Years of experience in Production department.

article thumbnail

ESMO 2022 Real-Time Roundup

InCrowd

The 2022 Annual Meeting of the European Society for Medical Oncology (ESMO) took place in person from September 9th to the 13th. InCrowd wanted to learn from those Medical Oncologists and Hematology-Oncologists who attended the following two objectives: Explore which tumor type/track had the most exciting data presented Understand what attendees found exciting about the tumor type data presented.

Medical 52
article thumbnail

Fireside Chat with Dr. Luca Dezzani, VP, US Oncology Medical Affairs at Johnson & Johnson

Impetus Digital

Register for Impetus’ upcoming live webinar on September 28, 2 – 3 PM ET: A Fireside Chat with Fireside Chat with Dr. Luca Dezzani, VP, US Oncology Medical Affairs at Johnson & Johnson. About the webinar. Dr. Luca Dezzani , VP of US Oncology Medical Affairs at Johnson & Johnson , will join Natalie Yeadon , Co-founder & CEO of Impetus Digital , for a discussion around innovation in Medical Affairs, new technologies for data dissemination and medical education, how to engage with

Medical 52
article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

Industrial automation hiring levels in the pharmaceutical industry rose in August 2022

Pharmaceutical Technology

The proportion of pharmaceutical companies hiring for industrial automation related positions rose in August 2022 compared with the equivalent month last year, with 52% of the companies included in our analysis recruiting for at least one such position. This latest figure was higher than the 49.7% of companies who were hiring for industrial automation related jobs a year ago but a decrease compared to the figure of 58.3% in July 2022.

article thumbnail

Fireside Chat with Marius Rus, Founder of StressLess | Tully

Impetus Digital

Register for Impetus’ upcoming live webinar on October 4, 9 – 10 AM ET: A Fireside Chat with Marius Rus, Founder of StressLess | Tully. About the webinar. Marius Rus , founder of StressLess –the startup behind Tully –will sit down with Natalie Yeadon , Co-founder & CEO of Impetus Digital, for a discussion around wearable technologies for children with ADHD, autism, and other mental health conditions.

article thumbnail

A Growing Factor In Life Sciences Jobs: Cost of Living Differences

PharmExec

With more people working from home, employers should rethink how cost-of-living impacts salary negotiations.

69
article thumbnail

AstraZeneca: Redefining Cancer Care

Pharmaceutical Commerce

AZ’s Greg Rossi talks about the company’s oncology activities and his vision for the future of cancer treatment.

52
article thumbnail

The New Clinical Trial Supply Chain: Resilient, Flexible, and Patient-Centric

The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.

article thumbnail

Pharmacy Focus: Technician Edition With NHA - The Expanding Opportunities of Pharmacy Technicians

Pharmacy Times

On this month's episode hosts Jeremy Sasser and Jessica Langley-Loep from the National Healthcareer Association welcome their guest Christine Cline-Dahlman, BFA, CPhT, the founder and owner of PharmTechForward.

article thumbnail

FDA Approves Bluebird Bio’s $3 Million CALD Treatment

PharmaTech

FDA granted accelerated approval to Skysona (elivaldogene autotemcel), which is designed to slow the progression of neurologic dysfunction in adolescents with CALD.

FDA 40
article thumbnail

Pfizer Reports Positive Study Results for Pneumococcal Conjugate Vaccine in Infants in the EU

Pharmacy Times

Pivotal top-line data demonstrate 20vPnC, if approved likely protects against 20 serotypes in 3-dose series and may offer the broadest serotype coverage of any PCV.

49
article thumbnail

FDA and NIH Enter Rare Neurodegenerative Diseases Partnership

PharmaTech

The Public-Private Partnership for Rare Neurodegenerative Diseases will work to enhance understanding and develop treatments for rare neurodegenerative diseases.

FDA 40
article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

article thumbnail

Pharmacy Measures and Policy Considerations for Pharmacy Practice

Pharmacy Times

There are several important policy issues that could impact pharmacists’ ability to positively affect the quality of care for patients through the use of pharmacy performance measures.

article thumbnail

Operational Impact of Annex 1 Update (Sept 2022)

PharmaTech

The update for EU annex 1 is more than a simple revision, solidifying the expectation that facility fully understand their processes and systems. .

40
article thumbnail

Nivolumab May Benefit Recurrence-Free Survival in Patients With Stage 2B/C Melanoma

Pharmacy Times

Nivolumab is a biomarker that has been shown to benefit the survival of patients with stage 2 melanoma patients compared with placebo.

article thumbnail

Boehringer Ingelheim Adopts Virtuosi VR Education Platform

PharmaTech

Boehringer Ingelheim will use Virtuosi to train employees at three aseptic sites across its network.

article thumbnail

Clinical Supply Strategies for CROs

When a CRO is bidding on a project where clinical supplies will be one of the aspects to manage on behalf of the client via a partner, leveraging the expertise of a chosen clinical supply partner can be a valuable resource in demonstrating the CRO’s understanding of and ability to deliver upon critical drug-supply related aspects of the project, and ability to hit key milestones such as FPI for their client.